Drug Screening Platform Using Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes and Optical Mapping
M. Gunawan, S. Sangha, S. Shafaattalab, E. Lin, D. Heims-Waldron, V. Bezzerides, Z. Laksman, G. F. Tibbits
This study develops a drug screening platform using human iPSC-derived atrial cardiomyocytes and optical mapping to evaluate atrial-selective compounds.
bioRxiv · Jul 14, 2020Pharmacology & Toxicology